Advertisement

Effects of a Synthetic bFGF Antagonist Peptide on the Proteome of 3T3 Cells Stimulated with bFGF

  • Xiaoping Wu
  • Xinglong Jia
  • Yuhua Ji
  • Cong Wang
  • Yonglin Yu
  • Susu Gao
  • Quchou Li
  • Xiaokun Li
Article

Abstract

It has been known that basic fibroblast growth factor (bFGF) plays an important role in tumor progression mainly due to its strong mitogenic activity. Antagonists targeting bFGF have been considered a potential strategy for cancer therapy via inhibiting cell proliferation induced by bFGF. We have previously obtained a high-affinity bFGF-binding peptide (named as P7) with strong inhibitory activity against bFGF-induced cell proliferation from the phage display random heptapeptide library. The aim of the present investigation was to synthesize the peptide P7 by solid phase method and explore the mechanisms of the inhibitory effect of P7-targeting bFGF stimulation on Balb/c 3T3 cells via proteomic analysis. Seven differentially expressed protein were identified, among which four were decreased by bFGF stimulation alone and increased by addition of P7, the other three were up-regulated by bFGF treatment alone and down-regulated by addition of P7. Among the identified proteins, epidermal fatty acid-binding protein (E-FABP) and low molecular weight phosphotyrosine protein phosphatase (LMW-PTP) take part in the regulation of cell proliferation. The results suggested P7 inhibited the bioactivities of bFGF possibly via influencing the expression of cellular proteins related to cell proliferation.

Keywords

BFGF antagonist peptide Solid phase Proteome Proliferation Epidermal fatty acid-binding protein 

Notes

Acknowledgments

This work was supported by grants from the National Natural Science Foundation of China (30973671, 81071800), the Natural Science Foundation of Guangdong Province of China (9151064001000031), the Natural Science Foundation of Zhejiang Province of China (Y2090292), the Fundamental Research Funds for the Central Universities (21609402), the Science and Technology Planning Project of Wenzhou (Y20090244), Guangdong Provincial “Thousand-Hundred-Ten Talent Project” (Wu X), and Guangdong Provincial Key Discipline in Biochemistry and Molecular biology.

References

  1. Beenken A, Mohammadi M (2009) The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov 8(3):235–253PubMedCrossRefGoogle Scholar
  2. Bossard C, Laurell H, Van den Berghe L, Meunier S, Zanibellato C, Prats H (2003) Translokin is an intracellular mediator of FGF-2 trafficking. Nat Cell Biol 5(5):433–439PubMedCrossRefGoogle Scholar
  3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem 72:248–254PubMedCrossRefGoogle Scholar
  4. Bratkovic T (2010) Progress in phage display: evolution of the technique and its application. Cell Mol Life Sci 67(5):749–767PubMedCrossRefGoogle Scholar
  5. Chuthapisith S, Layfield R, Kerr ID, Eremin O (2007) Principles of proteomics and its applications in cancer. Surgeon 5(1):14–22PubMedCrossRefGoogle Scholar
  6. Cronauer MV, Schulz WA, Seifert HH, Ackermann R, Burchardt M (2003) Fibroblast growth factors and their receptors in urological cancers: basic research and clinical implications. Eur Urol 43(3):309–319PubMedCrossRefGoogle Scholar
  7. Dailey L, Ambrosetti D, Mansukhani A, Basilico C (2005) Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev 16(2):233–247PubMedCrossRefGoogle Scholar
  8. Hagens G, Roulin K, Hotz R, Saurat JH, Hellman U, Siegenthaler G (1999) Probable interaction between S100A7 and E-FABP in the cytosol of human keratinocytes from psoriatic scales. Mol Cell Biochem 192(1–2):123–128PubMedCrossRefGoogle Scholar
  9. Münz M, Zeidler R, Gires O (2005) The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP. Cancer Lett 225(1):151–157PubMedCrossRefGoogle Scholar
  10. Neuhoff V, Arold N, Taube D, Ehrhardt W (1988) Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using coomassie brilliant blue G-250 and R-250. Electrophoresis 9(6):255–262PubMedCrossRefGoogle Scholar
  11. Park EK, Warner N, Mood K, Pawson T, Daar IO (2002) Low-molecular-weight protein tyrosine phosphatase is a positive component of the fibroblast growth factor receptor signaling pathway. Mol Cell Biol 22(10):3404–3414PubMedCrossRefGoogle Scholar
  12. Pierce JD, Fakhari M, Works KV, Pierce JT, Clancy RL (2007) Understanding proteomics. Nurs Health Sci 9(1):54–60PubMedCrossRefGoogle Scholar
  13. Rusnati M, Presta M (2007) Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. Curr Pharm Des 13(20):2025–2044PubMedCrossRefGoogle Scholar
  14. Samoylova TI, Morrison NE, Globa LP, Cox NR (2006) Peptide phage display: opportunities for development of personalized anti-cancer strategies. Anticancer Agents Med Chem 6(1):9–17PubMedCrossRefGoogle Scholar
  15. Sørensen V, Nilsen T, Wiedłocha A (2006) Functional diversity of FGF-2 isoforms by intracellular sorting. Bioessays 28(5):504–514PubMedCrossRefGoogle Scholar
  16. Wang C, Lin S, Nie Y, Jia X, Wang J, Xiao J, Wu J, Li X, Wu X (2010a) Mechanism of antitumor effect of a novel bFGF binding peptide on human colon cancer cells. Cancer Sci 101(5):1212–1218PubMedCrossRefGoogle Scholar
  17. Wang C, Lin S, Li X, Wu X (2010b) Mechanism of inhibitory effect of P7 on 3T3 cell proliferation induced by basic fibroblast growth factor. ACTA Pharmaceutica Sinica 45(3):314–317PubMedGoogle Scholar
  18. Wu X, Yan Q, Huang Y, Huang H, Su Z, Xiao J, Zeng Y, Wang Y, Nie C, Yang Y, Li X (2010) Isolation of a novel basic FGF-binding peptide with potent antiangiogenetic activity. J Cell Mol Med 14(1–2):351–356PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Xiaoping Wu
    • 1
    • 2
  • Xinglong Jia
    • 1
  • Yuhua Ji
    • 1
  • Cong Wang
    • 1
    • 2
  • Yonglin Yu
    • 1
  • Susu Gao
    • 1
  • Quchou Li
    • 1
  • Xiaokun Li
    • 2
  1. 1.Institute of Tissue Transplantation and ImmunologyJinan UniversityGuangzhouChina
  2. 2.School of Pharmaceutical ScienceWenzhou Medical CollegeWenzhouChina

Personalised recommendations